Organic-inorganic hybrid metal halide perovskites, an emerging class of solution processable photoactive materials, welcome a new member with a one-dimensional structure. Herein we report the synthesis, crystal structure and photophysical properties of one-dimensional organic lead bromide perovskites, C4N2H14PbBr4, in which the edge sharing octahedral lead bromide chains [PbBr4 2−]∞ are surrounded by the organic cations C4N2H14 2+ to form the bulk assembly of core-shell quantum wires. This unique one-dimensional structure enables strong quantum confinement with the formation of self-trapped excited states that give efficient bluish white-light emissions with photoluminescence quantum efficiencies of approximately 20% for the bulk single crystals and 12% for the microscale crystals. This work verifies once again that one-dimensional systems are favourable for exciton self-trapping to produce highly efficient below-gap broadband luminescence, and opens up a new route towards superior light emitters based on bulk quantum materials.
Chromium(VI) sites homogeneously dispersed in a transparent silica xerogel matrix have been investigated to determine the coordination environment and rationalize the Raman spectra. X-ray absorption fine structure (EXAFS) analysis gives a structure that is consistent with Cr containing two terminal oxygens and is bound to the silica by two Cr-O-Si linkages. The structure was refined to an R factor of 1.28%. The terminal CrdO bonds were found to have a bond length of 1.60 Å and bridging Cr-O bonds of 1.80 Å. The Raman spectrum, collected with 785 nm excitation above the absorption edge of the chromium, shows a strong band at 986 cm -1 and a resolved shoulder at 1001 cm -1 . Isotopic labeling and polarization studies of low concentrations of Cr (0.5 mol %) indicate that the strong 986 cm -1 band is the totally symmetric Cr(dO) 2 mode; however, the isotopic shift and strong polarization of the 1001 cm -1 mode preclude it from being the antisymmetric component of the terminal dioxo stretch. At higher concentrations (e5.0 mol %) the high-energy shoulder becomes a resolved peak at 1004 cm -1 . While isotopic labeling shifts the peak to a position predicted for the antisymmetric stretch, the polarization ratio increases but does not reach a value that is unambiguous for an antisymmetric mode.
The detailed mechanism by which ethylene polymerization is initiated by the inorganic Phillips catalyst (Cr/SiO 2 ) without recourse to an alkylating co-catalyst remains one of the great unsolved mysteries of heterogeneous catalysis. Generation of the active catalyst starts with reduction of Cr VI ions dispersed on silica. A lower oxidation state, generally accepted to be Cr II , is required to activate ethylene to form an organoCr active site. In this work, a mesoporous, optically transparent monolith of Cr VI /SiO 2 was prepared using sol-gel chemistry in order to monitor the reduction process spectroscopically. Using in situ UV-vis spectroscopy, we observed a very clean, step-wise reduction by CO of Cr VI first to Cr IV , then to Cr II . Both the intermediate and final states show XANES consistent with these oxidation state assignments, and aspects of their coordination environments were deduced from Raman and UV-vis spectroscopies. The intermediate Cr IV sites are inactive towards ethylene at 80 °C. The Cr II sites, which have long been postulated as the endpoint of CO reduction, were observed directly by high-frequency/high-field EPR spectroscopy. They react quantitatively with ethylene to generate the organoCr III active sites, characterized by X-ray absorption and UV-vis spectroscopy, which initiate polymerization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.